Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
The precision-treatment company saw stronger-than-expected sales in its first full quarter following the launch of Ayvakit.
The company had generally improved earnings.
No podcast episodes available.
BPMC earnings call for the period ending September 30, 2021.
BPMC earnings call for the period ending March 31, 2020.
BPMC earnings call for the period ending December 31, 2019.
BPMC earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.